Catherine M. Ambler
Publications by Year
Research Areas
Fuel Cells and Related Materials, Flame retardant materials and properties, Advanced Battery Materials and Technologies, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography
Most-Cited Works
- → Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S )-2,2-Difluorocyclopropyl)((1 R ,5 S )-3-(2-((1-methyl-1 H -pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)(2018)170 cited
- → Discovery of Clinical Candidate 1-{[(2 S ,3 S ,4 S )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design(2017)139 cited
- → Targeting Intestinal Transporters for Optimizing Oral Drug Absorption(2010)128 cited
- → High temperature transport properties of polyphosphazene membranes for direct methanol fuel cells(2003)117 cited
- → Synthesis of Polyphosphazenes with Sulfonimide Side Groups(2002)106 cited
- → Phenylphosphonic Acid Functionalized Poly[aryloxyphosphazenes](2002)100 cited
- → Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases(2020)73 cited
- → Intestinal Targeting of Drugs: Rational Design Approaches and Challenges(2013)54 cited
- → Side Group Exchange in Poly(organophosphazenes) with Fluoroalkoxy Substituents(2003)29 cited
- → Identification of (R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid Receptor Antagonist(2014)27 cited